NOXAFIL

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Croatia, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug NOXAFIL contains one active pharmaceutical ingredient (API):

1	Posaconazole UNII 6TK1G07BHZ - POSACONAZOLE
	Posaconazole inhibits the enzyme lanosterol 14α-demethylase (CYP51), which catalyses an essential step in ergosterol biosynthesis.
	Read more about Posaconazole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NOXAFIL Oral suspension	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J02AC04	Posaconazole	J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AC Triazole and tetrazole derivatives
Discover more medicines within J02AC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	527315120017517
EE	Ravimiamet	1218866, 1646175, 1646186, 1666065, 1873054
ES	Centro de información online de medicamentos de la AEMPS	05320001, 105320002, 105320004
FI	Lääkealan turvallisuus- ja kehittämiskeskus	027795, 151012, 433666, 476142
FR	Base de données publique des médicaments	62076503, 65644772, 69380042
GB	Medicines & Healthcare Products Regulatory Agency	100537, 245566, 245567, 280018
HK	Department of Health Drug Office	56439
IE	Health Products Regulatory Authority	88380, 88420
IL	מִשְׂרַד הַבְּרִיאוּת	6101, 8005
IT	Agenzia del Farmaco	037059019, 037059021
JP	医薬品医療機器総合機構	6179002H1029, 6179403A1028
LT	Valstybinė vaistų kontrolės tarnyba	1029696, 1074065, 1074066, 1075485
NL	Z-Index G-Standaard, PRK	117498, 120642, 79553
NZ	Medicines and Medical Devices Safety Authority	11912, 16186
PL	Rejestru Produktów Leczniczych	100143564, 100317604, 100367000
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64692001, W64693001, W64693002, W64694001
SG	Health Sciences Authority	13654P, 15045P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699636041284, 8699636041291, 8699636280799, 8699636791271
US	FDA, National Drug Code	0085-1328, 0085-4324, 0085-4331
ZA	Health Products Regulatory Authority	41/20.3/0719